1. Home
  2. UUUU vs NAMS Comparison

UUUU vs NAMS Comparison

Compare UUUU & NAMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Energy Fuels Inc (Canada)

UUUU

Energy Fuels Inc (Canada)

N/A

Current Price

$15.13

Market Cap

4.6B

Sector

Industrials

ML Signal

N/A

Logo NewAmsterdam Pharma Company N.V.

NAMS

NewAmsterdam Pharma Company N.V.

N/A

Current Price

$31.04

Market Cap

4.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
UUUU
NAMS
Founded
1987
2019
Country
United States
Netherlands
Employees
N/A
100
Industry
Mining & Quarrying of Nonmetallic Minerals (No Fuels)
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.6B
4.1B
IPO Year
2006
N/A

Fundamental Metrics

Financial Performance
Metric
UUUU
NAMS
Price
$15.13
$31.04
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
8
Target Price
$19.92
$46.75
AVG Volume (30 Days)
10.0M
1.3M
Earning Date
05-06-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$65,922,000.00
N/A
Revenue This Year
$126.63
$17.96
Revenue Next Year
$36.80
$540.65
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.24
$17.76
52 Week High
$27.90
$42.21

Technical Indicators

Market Signals
Indicator
UUUU
NAMS
Relative Strength Index (RSI) 35.60 40.44
Support Level $13.40 $30.34
Resistance Level $16.63 $31.72
Average True Range (ATR) 1.25 1.69
MACD -0.28 -0.56
Stochastic Oscillator 8.73 6.04

Price Performance

Historical Comparison
UUUU
NAMS

About UUUU Energy Fuels Inc (Canada)

Energy Fuels Inc is a critical mineral company based in the U.S. It produces several critical minerals, including uranium, vanadium, REEs (including NdPr, Dy and Tb) and HMS (including titanium and zirconium minerals). The company's project portfolio comprises uranium properties like Pinyon Plain Project, White Mesa Mill, Roca Honda Project, etc.; Heavy Minerals Sands project like Vara Mada Project, Donald Project, Bahia Project, etc.; the Nichols Ranch Project, and several other properties. The firm's reportable segments are: Uranium, REE, and HMS. Key revenue is generated from the Uranium segment, which is involved in conventional and ISR uranium extraction, recovery and sales of uranium from mineral properties, and the recycling of uranium-bearing materials generated by third parties.

About NAMS NewAmsterdam Pharma Company N.V.

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments. The Company has one reportable segment, which comprises the discovery, development, and commercialization of transformative therapies for cardio-metabolic diseases.

Share on Social Networks: